Kasper, B. (2014). Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: Subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072. Annals of oncology, 25(3), . https://doi.org/10.1093/annonc/mdt586
Chicago Style (17th ed.) CitationKasper, Bernd. "Long-term Responders and Survivors on Pazopanib for Advanced Soft Tissue Sarcomas: Subanalysis of Two European Organisation for Research and Treatment of Cancer (EORTC) Clinical Trials 62043 and 62072." Annals of Oncology 25, no. 3 (2014). https://doi.org/10.1093/annonc/mdt586.
MLA (9th ed.) CitationKasper, Bernd. "Long-term Responders and Survivors on Pazopanib for Advanced Soft Tissue Sarcomas: Subanalysis of Two European Organisation for Research and Treatment of Cancer (EORTC) Clinical Trials 62043 and 62072." Annals of Oncology, vol. 25, no. 3, 2014, https://doi.org/10.1093/annonc/mdt586.